WO2002080839A2 - Neuartige lichtschutz- und hautpflegemittel durch stabilisierte lichtschutz-komponenten und verminderung schädigender photoprodukte - Google Patents
Neuartige lichtschutz- und hautpflegemittel durch stabilisierte lichtschutz-komponenten und verminderung schädigender photoprodukte Download PDFInfo
- Publication number
- WO2002080839A2 WO2002080839A2 PCT/DE2002/001253 DE0201253W WO02080839A2 WO 2002080839 A2 WO2002080839 A2 WO 2002080839A2 DE 0201253 W DE0201253 W DE 0201253W WO 02080839 A2 WO02080839 A2 WO 02080839A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin care
- energy
- acceptor
- light
- lsk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q3/00—Selecting arrangements
- H04Q3/0016—Arrangements providing connection between exchanges
- H04Q3/0025—Provisions for signalling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/622—Coated by organic compounds
Definitions
- the present invention relates to the use of certain substances in light protection and skin care products. These substances are, on the one hand, suitable surface-modified nanoparticles (OM-NP) and, on the other hand, so-called supermolecules, in which several light protection molecules are either covalently linked to one or more acceptor molecules, either directly or via a framework.
- OM-NP suitable surface-modified nanoparticles
- supermolecules in which several light protection molecules are either covalently linked to one or more acceptor molecules, either directly or via a framework.
- the present invention further relates to light protection and skin care compositions which contain such substances.
- Sun protection and skin care products contain so-called light protection components (LSKn), which absorb radiation in the near ultraviolet and in the visible range and in this way reduce the negative effects of solar radiation on the skin.
- LSKn light protection components
- a typical representative of this group is 3- (4-methoxyphenyl) -2-propenoic acid-2-ethylhexyl ester (p-CH 3 OC 6 H - CH-CH-COO-CH 2 -CH (C 2 H 5 ) -CH 2 -CH 2 -CH 2 -CH 3 ), which is also called OMC (for octyl methoxycinnamate).
- OMC for octyl methoxycinnamate
- TiO 2 and ZnO are used today in light protection and skin care products, namely as free (ie only equipped with a coagulation protection) nanoparticle, they are not, or not sufficient, able to form harmful photoproducts, e.g. radicals to prevent and thus contribute to the fact that damage to the skin is reduced by the photoproducts and the respective LSK (the light protection molecule) in the sunscreen or skin care agent becomes more stable and therefore remains UV-absorbing over a longer period of time. Radicals in particular can trigger mutations in skin cells as photoproducts and thus contribute to the development of skin cancer.
- harmful photoproducts e.g. radicals to prevent and thus contribute to the fact that damage to the skin is reduced by the photoproducts and the respective LSK (the light protection molecule) in the sunscreen or skin care agent becomes more stable and therefore remains UV-absorbing over a longer period of time.
- Radicals in particular can trigger mutations in skin cells as photoproducts and thus contribute to the development of skin cancer.
- the inventor of the present application has set itself the task of making available a new class of sun protection and skin care products, the known light protection component (s) of which are modified in such a way that on the one hand they have a higher UV stability has (s) (so that the sunscreen only has to be applied to the body parts exposed to the sun at large or longer intervals), and on the other hand this reduces the formation of skin-damaging photoproducts and not only slows down the aging process of the skin, but also the risk of developing skin cancer is significantly reduced.
- the inventor of the present invention has achieved this object by providing the sun protection and skin care products as defined in the patent claims. He assumed that the damaging effects that the absorbed light energy has on the skin and the light protection component / the light protection molecule are caused by an energy or also by an electron transmission (from the light protection component electronically excited after light absorption). can be greatly reduced to a suitable energy or electron acceptor.
- the sun protection and skin care products according to the invention thus contain, in addition to the LSK (for example a cinnamic acid ester such as OMC), an energy or electron acceptor which functions together with the LSK as an energy or electron transmission system.
- LSK for example a cinnamic acid ester such as OMC
- energy or electron acceptor which functions together with the LSK as an energy or electron transmission system.
- These energy or electron transmission systems are OM-NP, in particular surface-modified metal nanoparticles (OM-MNP), which also include monolayer protected cluster molecules (cluster or MPC molecules protected with monolayers) and monolayer protected alloy clusters -Molecules (alloy clusters or MPAC molecules protected with monolayers), as defined in Ref. 6 count; Surface modified semiconductor nanoparticles (OM-HNP); Surface modified dye nanoparticles (OM-FNP); or super molecules.
- OM-MNP surface-modified metal nanoparticles
- OM-HNP Surface modified semiconductor nanoparticle
- All of these transmission systems are characterized by the fact that one molecule, but usually several molecules of an LSK (chemical or physical) is covalently attached to a nanoparticle (e.g. a dye, a metal or a semiconductor) or, in the case of a super molecule, directly or via a framework is / are bound to one or more acceptor molecules.
- a nanoparticle e.g. a dye, a metal or a semiconductor
- acceptor molecules can bind one or more light protection molecules.
- a light protection molecule can bind one or more acceptor molecules.
- the combination of an acceptor molecule / several light protection molecules is clearly preferred according to the invention.
- surface modified used in accordance with the invention means that the acceptor particles or molecules in sun protection and skin care products are present in the form bound to LSKn and form the energy / electron transmission system with the latter, the binding being a chemical or a physical bond, ie a covalent bond, an ionic interaction, a dipole-dipole interaction, van der Waals forces or hydrogen bonds as well as all combinations of these interactions / bonds can be.
- the bond is only covalent in super molecules. Covalent bonds to the LSK are also preferred for the other acceptors.
- Electron acceptors are particles (atom clusters, nanoparticles, molecules) that are able to accept an electron from the excited state of the LSK and this (then as a donor) while avoiding photochemical processes that lead to damaging products, to be returned to the LSK, after which the acceptor will be in its original state.
- Energy acceptors are particles (atom clusters, nanoparticles, molecules) that are able to To absorb energy from the LSK and to convert it quickly into heat while avoiding photochemical processes.
- Energy or electron transfer systems refer to the linkage of an energy / electron acceptor with one or more molecules of an LSK, the linkage being a physical or chemical bond. These transmission systems are the prerequisite for the LSK in the sunscreen to be stabilized, since the LSK releases its excitation energy / its electron in the Si state (after the solar energy has been absorbed) to the acceptor without triggering photochemical reactions. Examples of energy or electron transmission systems in the sense of the present invention are the surface-modified semiconductor and dye nanoparticles mentioned above, the MPC, the MPAC and the super molecules.
- Light protection component is a molecule (a light protection molecule) as it is contained in commercially available sunscreens to filter out the UV-A and B radiation from the sun and thus protect the skin from this radiation.
- LSK is defined as any type of chemical compound which absorbs the UV-A and / or UV-B radiation from the sunlight and in this way protects the human skin exposed to the sun from this radiation.
- Common LSKn are cinnamic acid esters, especially 3- (4-methoxyphenyl) -2-propenoic acid 2-ethylhexyl ester (sold
- a and B radiation and therefore a suitable LSK molecule is octyltriazon (sold as
- Nanoparticles are characterized in that their diameter is in the range from a few nanometers to about 100 nm.
- the diameter of the NP is preferably at most 20 mm.
- the diameter of the NPs is particularly preferably at most 10 nm.
- NPs consist, for example, of organic molecules (for example dye molecules), of metal atoms of one element (for example gold) or also for several elements (for example alloy clusters) and of the constituents of inorganic semiconductors (for example TiO, ZnO, Sn0 2 , WO 3 , Sb O 6 , ZrO etc.).
- Ref. 11 and 12 as further literature on NPn.
- supermolecules in which an energy or electron acceptor as the core is provided with a shell of LSK molecules covalently linked to it.
- An example of the core is a porphyrin scaffold.
- super molecule also includes a compound in which an inert framework molecule (e.g. glucose, bile acid, cyclodextrins, derivatives of adamantane, linear oligomers with e.g.
- -OH or -NH 2 as side groups is both an acceptor molecule or particle ( or also several) as well as one molecule or several molecules of an LSK, which means that the light-protection molecules are not bound directly, but rather (covalently) to the acceptor molecule or particle via the scaffold molecule.
- LSM light protection molecule
- energy or electron acceptor do?
- the goal is to reduce the distance between LSM and acceptor molecule to max. 10 nm to shorten the lifespan / half-life of the electronically excited state of the LSK.
- the acceptor molecule should have a very short life in the excited state. If both conditions are met, the average time is. which, for example, needs molecular oxygen to diffuse to one of the excited molecules / particles, is greater than the time required for the excited molecule / particles to return to its basic state.
- TiO 2 As already mentioned above, the use of TiO 2 together with LSKn in sunscreens has already been described in the prior art.
- the use according to the invention of TiO 2 is based on the fact that the LSMe, for example by means of functional groups, for "attachment” to the acceptor particles or the acceptor molecules are equipped.
- Attachment is again to be understood as a chemical or physical bond (see the previous and in particular the last paragraph before the "Definitions” section).
- the consequence of the "attachment” is a significantly reduced distance between the LSM and the acceptor particle, which according to the invention must not exceed the critical value of approximately 10 nm.
- the distance is preferably up to 5 nm or even only up to 3 nm. Particularly preferred values for this distance are 0.5 to 1 nm, 1 to 1.5 nm, 1.5 to 2 nm, 2 to 2, 5 nm and 2.5 to 3 nm.
- the size of the distance can be influenced by the fact that the
- Linker by means of which the LSK is covalently bound to the nanoparticles, is modified.
- exemplary linkers for MPC and MPAC molecules are thiol residues which have different lengths (see Ref. 6, Scheme 1).
- An exemplary and preferred embodiment for the attachment of cinnamic acid esters to TiO 2 and other semiconductor nanoparticles is that the ester is additionally provided with carboxyl groups, by means of which it interacts ionically with TiO 2 or the other semiconductor nanoparticles.
- Other semiconductor nanoparticles suitable according to the invention are SnO 2 and ZnO 2 nanoparticles, which can be “attached” to the ester accordingly.
- MPC and MPAC molecules for example surfaces modified, ie gold or other metal nanoparticles protected with a monolayer LSK, are used for the energy or electron transmission.
- the coating is carried out by means of so-called reactive groups ("self-assembly"), for example by means of thiols, in particular those in Ref. 6, especially the thiols shown there in Scheme 1.
- Other reactive groups are disulfides.
- Cluster molecules suitable according to the invention (which are actually atomic or alloy clusters) have a metallic core (metallic core), the metal being in particular a metal from groups Ib and VIII of the PSE (CAS version) and titanium.
- the precious metals are particularly suitable as "metallic core”.
- Preferred metallic cores are the noble metals Au, Ag, Cu, Pt and Pd.
- the metallic core of the MPAC molecules are alloys, in particular alloys of the metals of groups Ib and VIII of the PSE (CAS version), the alloys of noble metals being particularly suitable.
- Preferred metallic cores of the MPAC molecules are the noble metal alloys Au / Ag, Au / Cu, Au / Ag / Cu, Au / Pt, Au / Pd and Au / Ag / Cu / Pd.
- the use of the LSK / acceptor systems as NP is very particularly advantageous in the sense of the present invention.
- the shape / size of nanoparticles enables the total mass of dye, semiconductor and metal particles to be kept as low as possible. Furthermore, it allows the use of the nanoparticles due to their highly disperse distribution, with a very small amount of e.g. Precious metal (such as gold or platinum).
- a significantly reduced distance between the LSM and acceptor particles which, according to the invention, must not exceed the critical value of approximately 10 nm, is important for avoiding the formation of damaging photo products.
- the distance is preferably up to 5 nm or even only up to 3 nm. The better the overlap of the fluorescence band of the LSK and the absorption band of the energy acceptor, the greater the distance between the two molecules / Particles from each other. However, an emission of fluorescence or phosphorescence by the excited LSK is not a prerequisite for the effect of the energy acceptor.
- This reduced distance between the molecules / particles is due to the bond between LSK and Energy acceptor achieved, the bond being a chemical or a physical bond, i.e. a covalent bond, an ionic interaction, a dipole-dipole interaction, van der Waals forces or hydrogen bonds as well as all combinations of these interactions / bonds , Covalent bonds of the acceptor to the LSK are preferred.
- An LSK for example, has an absorption maximum at 320 nm, a fluorescence maximum at 360 nm and a phosphorescence maximum at 450 nm.
- An energy acceptor that is particularly suitable according to the invention would then be a molecule / particle that has an absorption band (not a maximum in the narrow sense) has, as shown by way of example in FIG. 1. In other words, the acceptor should have a good absorption in the range from about 350 to 450/500 nm.
- Examples of energy acceptors with a very short lifespan in the excited state are non-fluorescent compounds with an absorption band in the near UV and blue range of light. These include compounds of the following classes of dyes: azo dyes, carotenoids, quinoid dyes, quinoline derivatives, coumarin dyes (partially), fluorescein and derivatives, indigo dyes, pyrene derivatives, triarylmethane dyes, xanthene dyes; Po ⁇ hyrins or porphyrin derivatives, phthalocyanines, anirachinones, anthraquinone derivatives or mixtures of several of these dyes.
- an electron can be transferred from the excited state of the primary excited molecule (the LSK, for example the cinnamic acid ester) to a suitable electron acceptor (electron transfer).
- the LSK the primary excited molecule
- a suitable electron acceptor electron transfer
- a molecule or cluster of molecules is suitable as an electron acceptor if it is an empty or only half-occupied electron orbital which can take up the electron from the excited state of the LSK.
- the energy of the orbital (on the physical scale with the energy 0 for an electron in a vacuum) must be more negative than the energy of the orbital of the excitation state of the LSK.
- an electron is transferred from the electron acceptor back to the half-filled ground state orbital of the LSK within a very short period of time in order to suppress harmful secondary reactions (the electron acceptor thus also acts as an electron donor).
- An electron acceptor / donor is considered to be suitable for the invention if (i) the orbital (Si) which the electron is to accept from the excited Si state of the LSM is lower in energy than the S t orbital of the LSMs, and (ii) the So orbital of the acceptor that donates the electron to the LSM has a higher energy than the ground state orbital (So) of the LSM.
- the electron initially transferred from the LSK to an acceptor returns from there directly to the basic state orbital of the LSM. It is then a prerequisite for an electron acceptor / donor in the sense of the present invention that its Si orbital is energetically (if possible in the middle) between the So and Si state of the LSK. If this condition is met, and the critical distance of 3 nm between LSM and acceptor is also maintained or undershot, the half-life of the excited state / radical is short, since the electron transfers from LSK to the acceptor or from Si des Acceptor according to So the acceptor (alternatively: the LSM) very quickly.
- the distance between the LSM and the electron acceptor is preferably at most 3 nm, with particularly preferred distances being up to 2 or only up to approximately 1 nm. If the critical distance between the LSM and the electron acceptor / donor is greater than 3 nm, the electrons can no longer be transferred from one molecule to the other, which ultimately also no longer leads to a stabilization of the light protection component.
- All types of binding interaction can also be considered for the “attachment” of the electron acceptor / donor to the LSK: chemical and physical bonds, ie covalent bonds, ionic interactions, dipole-dipole interactions, van der Waals forces and hydrogen bonds Bonds, as well as all combinations of these interactions.
- Semiconductor nanoparticles offer themselves as electron acceptors.
- the semiconductor's conduction band acts as an electron acceptor and its valence band, from which an electron falls back to the basic state of the LSK, acts as a donor. Almost simultaneously with this electron transfer from the valence band to the LSK, an electron moves from the conduction band of the semiconductor into its valence band. Alternatively, the electron transfer can also take place directly from the conduction band to the basic state of the LSK. It is essential for the functioning of the electron transmission that the basic and excitation state of the LSK are energetically adapted to the position of the valence and conduction band of the semiconductor (or vice versa).
- Examples of electron acceptors in addition to the already mentioned TiO 2 are also SnO 2 , ZnO, ZrO, WO 3 as semiconductors and as electron acceptors in supermolecules quinoid compounds, which essentially have the acceptor qualities, but not the toxicity, of the model system later on have mentioned di-octadecyl-4,4'-bipyridinium perchlorate. All molecules which have a more positive reduction potential on the electrochemical scale than the LSK are suitable as electron acceptors. Therefore, the electron acceptor must be adapted to the LSK (extensive table with reduction potentials in Ref. 8 and 17). MPC / MPAC molecules can act as both energy and electron acceptors, but energy transfer has a larger critical distance and is therefore more efficient than electron transfer.
- Suitable energy / electron acceptors such as the MPC-.MPAC molecules can best be produced as described in Ref. 6 and 9 to 12.
- the metal (core) is coated with a monolayer from LSK, e.g. des (3- (4-methoxyphenyl) -2-propenoic acid 2-ester, whose ethyl hexyl residue has been replaced, for example, by a short hydrocarbon chain with at least one thiol group.
- LSK monolayer from LSK
- des 3- (4-methoxyphenyl) -2-propenoic acid 2-ester, whose ethyl hexyl residue has been replaced, for example, by a short hydrocarbon chain with at least one thiol group.
- the "attachment" of the LSK to the core -Metal using disulfides see ref. 9).
- a newer technique is based on dendrimers which enclose the nanoparticles formed (ref. 10).
- the production of the supermolecules consisting of LSK and acceptor molecule and, if necessary, a framework part is carried out in analogy to the synthesis of numerous supermolecules were used to research electron transfer (energy dependence, distance dependence) (see ref. 13 - 16).
- the individual components are linked in different ways, for example by A id or ester bonds. Furthermore, in the case of conjugated systems, double bonds are formed between the components; ether bonds and thioether bonds are also to be used.
- the framework part should provide known reactive groups, for example -OH, -SH, -NH 2 . COOH.
- framework parts are glucose, bile acid, cyclodextrins, glycerol, adamantane derivatives, furthermore oligomeric methacrylic acid, polyvinyl alcohol, polyallylamine, to whose functional groups both LSK and acceptors can be bound using known methods.
- the LSK and acceptor can be equipped with polymerizable or polycondensable groups and polymerized or polycondensed in a suitable ratio to oligomers.
- the concept of stabilizing light protection and skin care products by energy or electron transfer and reducing the formation of harmful photo products is the essential prerequisite of the present invention.
- the basics of energy and electron transfer have been extensively investigated in systems of monomolecular layers (reference 3).
- the new light protection and skin care products based on energy transfer or electron transfer mean a significant improvement over the conventional light protection and skin care products due to their increased light stability and reduced formation of harmful photo products, which means e.g. the addition of antioxidants can be reduced.
- FIG. 1 shows the absorption spectrum of a monolayer of gold nanoparticles, coated with octylthiol, on glass.
- FIG. 4 shows the absorption spectra of system A (see examples 2 and 3) after different irradiation times.
- FIG. 5 shows the absorption spectra of system B (see examples 2 and 3) after different irradiation times.
- Figure 6 shows the evaluation of those shown in Fig. 4 (squares) and 5 (circles)
- Fig. 7 shows the absorption spectra of system C after various irradiation times
- FIG. 8 shows the absorption spectra of system D after various irradiation times
- Figure 9 represents the evaluation of those shown in Figures 7 (squares) and 8 (circles)
- a transfer of the monofilms from the water surface to glass plates was attempted by immersing the plates vertically through the film at constant thrust (Langmuir-Blodgett technique). The transfer is tracked by registering the area decrease of the film on the water surface during the diving process.
- EA eicosylamine
- the gold nanoparticles are separated from the cinnamic acid ester by the layer of octyl residues on the gold and the long hydrocarbon chains by OMA and the substituents by EU.
- the distance is approximately 3 nm.
- the electron acceptor di-octadecyl-4,4'-bipyridinium perchlorate was used to set up model systems for electron transfer.
- the dimethyl derivative is a strong poison due to the blockage of electron transfer processes in biological systems. Therefore, the dioctadecyl derivative is only to be understood as a model and is not suitable for actual use in sunscreens. It is used here in a mixed layer with stearic acid (Cj 8 ) in a molar ratio of 1:10, since it has proven itself as an acceptor in studies of electron transfer (reference 3).
- the systems examined are:
- System C glass, TEA 40, 4-EU: OMA 1: 2 10, TC 18 20
- System D glass, TEA 40, -lEU: OMA 1: 2 10, TS135: C 18 1: 1020
- Example 3 Increasing light stability through energy transmission
- FIG. 4 shows absorption spectra of a glass plate with System A before the irradiation and after irradiation with white light of a 200 W mercury lamp with increasing irradiation times t: 5 minutes, 15 minutes and 30 minutes. The absorption decreases significantly with the irradiation.
- corresponding absorption spectra of a glass plate with system B are shown in FIG. 5.
- the comparison of FIG. 4 and FIG. 5 immediately shows that the light stability of EU in the presence of the layer of gold nanoparticles is significantly increased at a distance of approximately 3 nm.
- FIGS. 7 system C without electron acceptor
- 8 system D with electron acceptor
- FIGS. 7 and 8 show the absorption spectra before and after 5, 15 and 30 minutes of irradiation under the same conditions with white 200 Hg lamp light.
- the decrease in absorption is significantly reduced in system D compared to system C, which is also clearly shown by the evaluation in FIG. 9 (analogous to FIG. 6).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Catching Or Destruction (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002256609A AU2002256609B2 (en) | 2001-04-06 | 2002-04-05 | Novel stabilising light-protection and skincare agents containing stabilised light-protection components and reduction of damaging light products |
US10/474,010 US20040170579A1 (en) | 2001-04-06 | 2002-04-05 | Novel stabilising light-protection and skincare agents containing stabilised light-protection components and reduction of damaging light products |
EP02726077A EP1377250A2 (de) | 2001-04-06 | 2002-04-05 | Neuartige lichtschutz- und hautpflegemittel durch stabilisierte lichtschutz-komponenten und verminderung schädigender photoprodukte |
DE10291420T DE10291420D2 (de) | 2001-04-06 | 2002-04-05 | Neuartige Lichtschutz- und Hautpflegemittel durch stabilisierte Lichtschutz-Komponenten und Verminderung schädigender Photoprodukte |
CA002443631A CA2443631A1 (en) | 2001-04-06 | 2002-04-05 | Novel stabilising light-protection and skincare agents containing stabilised light-protection components and reduction of damaging light products |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10117336.9 | 2001-04-06 | ||
DE10117336A DE10117336A1 (de) | 2001-04-06 | 2001-04-06 | Neuartige Lichtschutz- und Hautpflegemittel durch stabilisierte Lichtschutz-Komponenten und Verminderung schädigender Photoprodukte |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002080839A2 true WO2002080839A2 (de) | 2002-10-17 |
WO2002080839A3 WO2002080839A3 (de) | 2003-09-04 |
Family
ID=7680726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2002/001253 WO2002080839A2 (de) | 2001-04-06 | 2002-04-05 | Neuartige lichtschutz- und hautpflegemittel durch stabilisierte lichtschutz-komponenten und verminderung schädigender photoprodukte |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040170579A1 (de) |
EP (1) | EP1377250A2 (de) |
AU (1) | AU2002256609B2 (de) |
CA (1) | CA2443631A1 (de) |
DE (2) | DE10117336A1 (de) |
WO (1) | WO2002080839A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7186274B2 (en) | 2002-04-08 | 2007-03-06 | L'oreal | Method for treating human keratin fibers with organomodified metallic particles |
FR2838052B1 (fr) * | 2002-04-08 | 2005-07-08 | Oreal | Utilisation de particules metalliques organomodifiees pour le traitement de fibres keratiniques humaines |
FR2847812B1 (fr) * | 2002-11-28 | 2006-04-14 | Louis Dubertret | Composition cosmetique comprenant des nanoparticules fluorescentes comme pigments |
FR2850271B1 (fr) * | 2003-01-27 | 2006-08-04 | Oreal | Utilisation de nanoparticules semiconductrices luminescentes en cosmetique |
US7736631B2 (en) | 2003-04-01 | 2010-06-15 | L'oreal S.A. | Cosmetic dye composition with a lightening effect for human keratin materials, comprising at least one fluorescent dye and at least one aminosilicone, and process of dyeing |
DE102005019391A1 (de) * | 2005-04-25 | 2006-10-26 | Merck Patent Gmbh | Nanopartikel |
KR20090043579A (ko) * | 2006-08-23 | 2009-05-06 | 유니레버 엔.브이. | 선스크린 조성물 |
US8133477B2 (en) * | 2007-08-09 | 2012-03-13 | Hallstar Innovations Corp. | Dispersions of inorganic particulates containing alkoxycrylene |
US8070989B2 (en) | 2007-08-09 | 2011-12-06 | Hallstar Innovations Corp. | Photostabilization of retinoids with alkoxycrylene compounds |
US7754191B2 (en) * | 2007-08-09 | 2010-07-13 | Hallstar Innovations Corp. | Method of quenching electronic excitation of chromophore-containing organic molecules photoactive compositions |
US8263051B2 (en) | 2007-08-09 | 2012-09-11 | Hallstar Innovations Corp. | Photostabilization of resveratrol with alkoxycrylene compounds |
US7597825B2 (en) * | 2007-08-09 | 2009-10-06 | Hallstar Innovations Corp. | Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions |
US8329148B1 (en) | 2007-08-09 | 2012-12-11 | Hallstar Innovations Corp. | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds |
US7776614B2 (en) * | 2007-08-09 | 2010-08-17 | Hallstar Innovations Corp. | Test method for determining compounds capable of quenching electronic singlet state excitation of photoactive compounds |
US7588702B2 (en) | 2007-08-09 | 2009-09-15 | Hallstar Innovations Corp. | Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions |
US8431112B2 (en) | 2007-08-09 | 2013-04-30 | Hallstar Innocations Corp. | Photostabilization of cholecalciferol with alkoxycrylene compounds |
US8257687B2 (en) | 2007-08-09 | 2012-09-04 | Hallstar Innovations Corp. | Photostabilization of coenzyme Q compounds with alkoxycrylene compounds |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
BR112013007496A2 (pt) | 2010-08-27 | 2019-09-24 | Sienna Labs Inc | composições e métodos para termo modulação específica |
CN108480620A (zh) | 2012-10-11 | 2018-09-04 | 纳诺康波西克斯公司 | 银纳米片组合物及方法 |
CA2925539A1 (en) * | 2013-10-16 | 2015-04-23 | University Of South Alabama | Formulations including silver nanoparticles and methods of using the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035415A1 (de) * | 1998-12-11 | 2000-06-22 | Cognis Deutschland Gmbh | Verwendung von nanoskaligen organischen uv-lichtschutzfiltern |
WO2001093822A2 (de) * | 2000-06-08 | 2001-12-13 | Henkel Kommanditgesellschaft Auf Aktien | Wässrige dispersionen nanopartikulärer lichtschutzfilter |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5243064A (en) * | 1986-06-27 | 1993-09-07 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
US5230874A (en) * | 1986-06-27 | 1993-07-27 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US5733531A (en) * | 1991-02-05 | 1998-03-31 | Sunsmart, Inc. | Composite UV sunblock compositions |
US5720805A (en) * | 1993-04-13 | 1998-02-24 | Southwest Research Institute | Titanium-tin-oxide nanoparticles, compositions utilizing the same, and the method of forming the same |
US6037019A (en) * | 1995-08-24 | 2000-03-14 | 3M Innovative Properties Company | Process for making particle-coated solid substrates |
US6306384B1 (en) * | 1996-10-01 | 2001-10-23 | E-L Management Corp. | Skin battery cosmetic composition |
GB9811377D0 (en) * | 1998-05-27 | 1998-07-22 | Isis Innovations Ltd | Compositions |
-
2001
- 2001-04-06 DE DE10117336A patent/DE10117336A1/de not_active Withdrawn
-
2002
- 2002-04-05 DE DE10291420T patent/DE10291420D2/de not_active Expired - Fee Related
- 2002-04-05 WO PCT/DE2002/001253 patent/WO2002080839A2/de not_active Application Discontinuation
- 2002-04-05 AU AU2002256609A patent/AU2002256609B2/en not_active Ceased
- 2002-04-05 US US10/474,010 patent/US20040170579A1/en not_active Abandoned
- 2002-04-05 CA CA002443631A patent/CA2443631A1/en not_active Abandoned
- 2002-04-05 EP EP02726077A patent/EP1377250A2/de not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035415A1 (de) * | 1998-12-11 | 2000-06-22 | Cognis Deutschland Gmbh | Verwendung von nanoskaligen organischen uv-lichtschutzfiltern |
WO2001093822A2 (de) * | 2000-06-08 | 2001-12-13 | Henkel Kommanditgesellschaft Auf Aktien | Wässrige dispersionen nanopartikulärer lichtschutzfilter |
Non-Patent Citations (1)
Title |
---|
See also references of EP1377250A2 * |
Also Published As
Publication number | Publication date |
---|---|
EP1377250A2 (de) | 2004-01-07 |
WO2002080839A3 (de) | 2003-09-04 |
CA2443631A1 (en) | 2002-10-17 |
US20040170579A1 (en) | 2004-09-02 |
DE10117336A1 (de) | 2002-10-10 |
DE10291420D2 (de) | 2004-04-15 |
AU2002256609B2 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1377250A2 (de) | Neuartige lichtschutz- und hautpflegemittel durch stabilisierte lichtschutz-komponenten und verminderung schädigender photoprodukte | |
DE69710571T2 (de) | Mikrokabeln aus chitin oder chitinderivaten, die eine hydrophobe substanz, insbesondere ein sonnenschutzfilter enthalten, und methode zur herstellung solcher mikrokapseln | |
DE69510500T2 (de) | Kosmetische Sonnenschutzmittel und Verwendungen | |
EP0683662B1 (de) | Wasserfeste kosmetische oder dermatologische lichtschutzzubereitungen | |
DE60033279T2 (de) | Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel | |
DE4303983C2 (de) | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an anorganischen Mikropigmenten | |
DE60106275T2 (de) | Dermatologische zusammensetzung | |
AT400399B (de) | Lichtstabiles kosmetisches mittel zum schutz der humanepidermis vor uv-strahlen sowie verfahren zur stabilisierung von 4-(1,1 dimethylethyl)-4'-methoxydibenzoylmethan vor uv-bestrahlung | |
EP0987005A2 (de) | Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl | |
DE69531492T2 (de) | Stabilisierung lichtempfindlicher materialien | |
DE69800556T2 (de) | Ein Zimtsäurederivat und ein Polyamin-Polymer enthaltende Zusammensetzung | |
DE19545789C2 (de) | Verwendung von Isoalkansäuren | |
DE69800513T2 (de) | Zusammensetzung, die ein Dibenzoylmethanderivat und ein Polyaminpolymer enthält | |
EP0876136B1 (de) | Stabile kosmetische und dermatologische lichtschutzzubereitungen in form von w/o-emulsionen mit einem gehalt an anorganischen mikropigmenten, triazinderivaten und/oder weiteren komponenten | |
DE19750030A1 (de) | Lichtstabile kosmetische Formulierung enthaltend Butylmethoxydibenzoylmethan | |
DE19811692A1 (de) | Sonnenschutzformulierungen mit Wirkung gegen Herpes Simplex Viren | |
WO2007014644A1 (de) | Stabile wirkstoffkombinationen auf der grundlage von folsäure | |
DE4443243A1 (de) | Sonnenschutzzubereitung mit erhöhtem Lichtschutzfaktor | |
DE2032914A1 (de) | ||
EP1022017A2 (de) | Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität | |
DE19856947A1 (de) | Sonnenschutzmittel | |
EP0895775B1 (de) | Lichtschutzbereitungen mit einem Gehalt an anorganischen Pigmenten, welche oberflächlich mit UV-Filtersubstanzen beschichtet sind | |
DE10007116A1 (de) | Wäßrige Dispersion wasserunlöslicher organischer UV-Filtersubstanzen | |
DE19602617A1 (de) | Stabile kosmetische und dermatologische Lichtschutzzubereitungen in Form von O/W-Emulsionen mit einem Gehalt an anorganischen Mikropigmenten, Triazinderivaten und weiteren Komponenten | |
EP1077673B1 (de) | Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an triazinderivaten und einem oder mehreren estern verzweigtkettiger carbonsäuren und verzweigtkettiger alkohole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2443631 Country of ref document: CA Ref document number: 2002256609 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002726077 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002726077 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10474010 Country of ref document: US |
|
REF | Corresponds to |
Ref document number: 10291420 Country of ref document: DE Date of ref document: 20040415 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10291420 Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |